We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Motivational Enhancement for Spanish Speaking Individuals - 1

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00078169
First Posted: February 23, 2004
Last Update Posted: January 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
University of Miami
Information provided by:
National Institute on Drug Abuse (NIDA)
  Purpose
The purpose of this study is to compare a three-session Spanish version of Motivational Enhancement Therapy (MET) to standard treatment to see how well MET engages and retains Spanish-speaking clients in outpatient substance abuse treatment.

Condition Intervention Phase
Substance-Related Disorders Behavioral: Behavior Therapy Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Motivational Enhancement for Spanish Speaking Individuals

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Treatment retention, drug and alcohol abstinence

Estimated Enrollment: 463
Study Start Date: November 2003
Study Completion Date: October 2005
Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 99 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

All subjects included unless medical/psychiatrically unstable

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00078169


Locations
United States, Colorado
Island Grove RTC
Greeley, Colorado, United States, 80631
United States, Florida
Miami Behavioral Health
Miami, Florida, United States, 33161
United States, New Mexico
Counseling & Psychotherapy Institute
Albuquerque, New Mexico, United States, 87194
The Life Link
Santa Fe, New Mexico, United States, 87505
United States, New York
Narco Freedom (Bridge Plaza)
Long Island City, New York, United States, 11101
United States, Oregon
Changepoint - Cedar Hills Blvd
Portland, Oregon, United States, 97292
Changepoint, Inc.
Portland, Oregon, United States, 97402
Sponsors and Collaborators
Yale University
University of Miami
Investigators
Principal Investigator: Kathleen Carroll, Ph.D. Yale University
  More Information

Responsible Party: Kathleen Carroll, Ph.D., Yale University School of Medicine
ClinicalTrials.gov Identifier: NCT00078169     History of Changes
Other Study ID Numbers: NIDA-CTN-0021-1
First Submitted: February 19, 2004
First Posted: February 23, 2004
Last Update Posted: January 12, 2017
Last Verified: October 2016

Keywords provided by National Institute on Drug Abuse (NIDA):
behavioral intervention

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders